Donna Burroughs
Adult Health · Anderson, SCNPI 1831213545
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations.
Across 236 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$394
- Lilly USA, LLC$357
- Xeris Pharmaceuticals, Inc.$318
- Novo Nordisk$305
- Insulet Corporation$301
- AstraZeneca$215
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,706100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 41 | $394 |
| Lilly USA, LLC | 21 | $357 |
| Xeris Pharmaceuticals, Inc. | 18 | $318 |
| Novo Nordisk | 18 | $305 |
| Insulet Corporation | 9 | $301 |
| AstraZeneca(2 entities) | 14 | $215 |
| Amgen | 12 | $185 |
| Sanofi-aventis U.S. LLC | 14 | $181 |
| Novartis | 9 | $161 |
| Dexcom, Inc. | 9 | $149 |
| AbbVie | 8 | $109 |
| Medtronic | 5 | $104 |
| Boehringer Ingelheim | 6 | $91 |
| Tandem Diabetes Care, Inc. | 3 | $86 |
| Ultragenyx Pharmaceutical Inc. | 4 | $77 |
| Corcept Therapeutics | 5 | $69 |
| Abbott | 4 | $62 |
| Ascendis Pharma Endocrinology Inc | 3 | $56 |
| Recordati_rare_diseases_inc. | 3 | $54 |
| IBSA Pharma Inc. | 3 | $53 |
| Antares Pharma, Inc. | 4 | $52 |
| BD | 3 | $44 |
| Clarus Therapeutics Inc. | 7 | $43 |
| Amryt Pharma Holdings Ltd | 2 | $39 |
| Zealand Pharma US, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| Cequr Corporation | 2 | $26 |
| Nevro Corp. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Mannkind Corporation | 1 | $18 |
| Merck | 1 | $15 |
How this compares
$3,706 in reported general payments places this provider in the 75th percentile of 292 adult health providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 124 | $140,579 |
| JardianceEmpagliflozin | 99 | $113,705 |
| TrulicityDulaglutide | 89 | $111,702 |
| Tresiba Flextouch U-200Insulin Degludec | 81 | $97,051 |
| OzempicSemaglutide | 44 | $66,433 |
| Novolog FlexpenInsulin Aspart | 102 | $36,288 |
| Humalog Kwikpen U-200Insulin Lispro | 18 | $35,432 |
| FarxigaDapagliflozin Propanediol | 21 | $27,527 |
| JanuviaSitagliptin Phosphate | 16 | $18,134 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 91 | $13,351 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 12 | $13,296 |
| Humalog Kwikpen U-100Insulin Lispro | 27 | $10,806 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $10,258 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 79 | $10,211 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $5,348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $91 | $113,70599 claims |
| Lilly USA, LLCTrulicity | $357 | $111,70289 claims |
| Novo NordiskOzempic | $305 | $66,43344 claims |
| MerckJanuvia, Janumet Xr | $15 | $28,39228 claims |
| AstraZenecaFarxiga | $215 | $27,52721 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $19525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 292 adult health providers in South Carolina.
Other adult health in Anderson
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
- Christi WigginsWest Columbia$10K
- Mary BairdSumter$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.